Last updated: May 10, 2024
Sponsor: Centre Hospitalier Henri Duffaut - Avignon
Overall Status: Terminated
Phase
N/A
Condition
Cancer
Colon Cancer
Bone Neoplasm
Treatment
Osteopathic intervention
QLQ-C30 questionnaire
CRP assessment
Clinical Study ID
NCT04718610
OSTEOCAN
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patient with lung cancer or colorectal cancer or Non Hodgkin Lymphoma or MultipleMyeloma (Stade I à IV)
No previous treatment
HRV < 70 ms
No osteopathic contraindication
Exclusion
Exclusion Criteria:
Vagotomy
Heart arrhythmia
Cancer recurrence
Consumption of coffee or tabac within 2 hours prior osteopathic treatment
Consumption of alcohol within 24 hours prior osteopathic treatment
Study Design
Total Participants: 25
Treatment Group(s): 3
Primary Treatment: Osteopathic intervention
Phase:
Study Start date:
January 12, 2021
Estimated Completion Date:
September 19, 2021
Connect with a study center
Centre Hospitalier Henri Duffaut
Avignon, 84000
FranceSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.